Home › GlaxoSmithKline: An Undervalued 'Work In Progress'
 

Keywords :   


GlaxoSmithKline: An Undervalued 'Work In Progress'

2015-07-05 11:01:15| Biotech - Topix.net

GlaxoSmithKline has hit some rough patches over the years, leaving shares looking cheap. A dividend around 5.5% isn't too shabby, either.

Tags: work progress glaxosmithkline undervalued

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news
»
27.11
27.11MTG 4
27.1119
27.11
27.11Y-3
27.11
27.1125th PSA10
27.11REVO9
More »